Filtros de búsqueda

Lista de obras de Axel Le Cesne

A comprehensive review of the current evidence for trabectedin in advanced myxoid liposarcoma

scientific article published on 15 November 2018

A comprehensive review on the diagnosis and management of intimal sarcoma of the pulmonary artery

artículo científico publicado en 2020

A double-blind placebo-controlled randomized phase II trial assessing the activity and safety of regorafenib in non-adipocytic sarcoma patients previously treated with both chemotherapy and pazopanib

artículo científico publicado en 2020

A phase 1 and randomized controlled phase 2 trial of the safety and efficacy of the combination of gemcitabine and docetaxel with ontuxizumab (MORAb-004) in metastatic soft-tissue sarcomas

scientific article published on 29 April 2019

A phase I study of SAR405838, a novel human double minute 2 (HDM2) antagonist, in patients with solid tumours

artículo científico publicado en 2017

A phase II study of ET-743/trabectedin ('Yondelis') for patients with advanced gastrointestinal stromal tumours

artículo científico publicado en 2004

A phase II study of gefitinib for patients with advanced HER-1 expressing synovial sarcoma refractory to doxorubicin-containing regimens

artículo científico publicado en 2008

A phase II trial of panobinostat in patients with advanced pretreated soft tissue sarcoma. A study from the French Sarcoma Group

artículo científico publicado en 2013

A retrospective analysis of antitumour activity with trabectedin in translocation-related sarcomas

artículo científico publicado en 2012

A retrospective pooled analysis of trabectedin safety in 1,132 patients with solid tumors treated in phase II clinical trials

article

A role for adjuvant RFA in managing hepatic metastases from gastrointestinal stromal tumors (GIST) after treatment with targeted systemic therapy using kinase inhibitors

artículo científico publicado en 2013

A role for maintenance therapy in managing sarcoma

artículo científico

Abdominal desmoplastic small round cell tumor: multimodal treatment combining chemotherapy, surgery, and radiotherapy is the best option

artículo científico publicado en 2014

Absence of progression as assessed by response evaluation criteria in solid tumors predicts survival in advanced GI stromal tumors treated with imatinib mesylate: the intergroup EORTC-ISG-AGITG phase III trial

artículo científico publicado en 2009

Abstract LB-295: Detection of oncogenic kinase mutations in circulating plasma DNA and correlation with clinical benefit in the phase III GRID study of regorafenibvsplacebo in TKI-refractory metastatic GIST

article

Activity of Pazopanib and Trabectedin in Advanced Alveolar Soft Part Sarcoma

artículo científico publicado en 2017

Activity of eribulin mesylate in patients with soft-tissue sarcoma: a phase 2 study in four independent histological subtypes.

artículo científico publicado en 2011

Adjuvant chemotherapy in localized soft tissue sarcomas: still not proven

scientific article published on 06 October 2009

Adjuvant chemotherapy with doxorubicin, ifosfamide, and lenograstim for resected soft-tissue sarcoma (EORTC 62931): a multicentre randomised controlled trial.

artículo científico publicado en 2012

Adjuvant therapy in primary GIST: state-of-the-art

artículo científico publicado en 2012

Adjuvant treatment of GIST with imatinib: solid ground or still quicksand? A comment on behalf of the EORTC Soft Tissue and Bone Sarcoma Group, the Italian Sarcoma Group, the NCRI Sarcoma Clinical Studies Group (UK), the Japanese Study Group on GIST

artículo científico publicado en 2009

Advanced chordoma treated by first-line molecular targeted therapies: Outcomes and prognostic factors. A retrospective study of the French Sarcoma Group (GSF/GETO) and the Association des Neuro-Oncologues d'Expression Française (ANOCEF).

artículo científico publicado en 2017

Advanced well-differentiated/dedifferentiated liposarcomas: role of chemotherapy and survival

artículo científico publicado en 2011

Aggressive Surgery in Retroperitoneal Soft Tissue Sarcoma Carried Out at High-Volume Centers is Safe and is Associated With Improved Local Control

scientific article published on 01 June 2010

Alternatively spliced NKp30 isoforms affect the prognosis of gastrointestinal stromal tumors

artículo científico publicado en 2011

An unusual variant of diffuse retinoblastoma in an adult

artículo científico publicado en 2008

Antiangiogenic effects in patients with progressive desmoplastic small round cell tumor: data from the French national registry dedicated to the use of off-labeled targeted therapy in sarcoma (OUTC's)

artículo científico publicado en 2017

Assessing Prognostic and Predictive Biomarkers of Regorafenib Response in Patients with Advanced Soft Tissue Sarcoma: REGOSARC Study

artículo científico publicado en 2020

Attenuation of soft-tissue sarcomas resistance to the cytotoxic action of TNF-α by restoring p53 function

artículo científico publicado en 2012

Baseline and early lymphopenia predict for the risk of febrile neutropenia after chemotherapy

artículo científico publicado en 2003

Basic Knowledge in Soft Tissue Sarcoma

scientific article published on 24 June 2019

Brain Metastases and Place of Antiangiogenic Therapies in Alveolar Soft Part Sarcoma: A Retrospective Analysis of the French Sarcoma Group

scientific article published on 09 January 2019

Brostallicin, an agent with potential activity in metastatic soft tissue sarcoma: a phase II study from the European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group

artículo científico publicado en 2006

CD4+CD25+ regulatory T cells inhibit natural killer cell functions in a transforming growth factor-beta-dependent manner

artículo científico publicado en 2005

CTNNB1 45F mutation is a molecular prognosticator of increased postoperative primary desmoid tumor recurrence: an independent, multicenter validation study.

artículo científico publicado en 2013

Chemotherapy in patients with desmoid tumors: a study from the French Sarcoma Group (FSG).

artículo científico publicado en 2011

Clear cell sarcoma (malignant melanoma) of soft parts: a clinicopathologic study of 52 cases

artículo científico publicado en 2012

Clinical evaluation of continuous daily dosing of sunitinib malate in patients with advanced gastrointestinal stromal tumour after imatinib failure

artículo científico publicado en 2009

Clinicopathologic, phenotypic, and genotypic characteristics of gastrointestinal mesenchymal tumors

artículo científico publicado en 2004

Complete longitudinal analyses of the randomized, placebo-controlled, phase III trial of sunitinib in patients with gastrointestinal stromal tumor following imatinib failure

artículo científico publicado en 2012

Consistent Margin-Status Reporting in Soft Tissue Sarcoma Is Essential to Establish Risk-Adapted Strategies Integrating Biology and Histotype in Perioperative Treatments

artículo científico publicado en 2018

Cutaneous side-effects of kinase inhibitors and blocking antibodies

artículo científico publicado en 2005

Cytokine and angiogenic factors associated with efficacy and toxicity of pazopanib in advanced soft-tissue sarcoma: an EORTC-STBSG study

artículo científico publicado en 2012

Denosumab in patients with giant-cell tumour of bone: a multicentre, open-label, phase 2 study.

artículo científico publicado en 2019

Desmoid-type fibromatosis and pregnancy: a multi-institutional analysis of recurrence and obstetric risk.

artículo científico publicado en 2014

Desmoid-type fibromatosis: a front-line conservative approach to select patients for surgical treatment.

artículo científico publicado en 2009

Development of a disease-specific graded prognostic assessment index for the management of sarcoma patients with brain metastases (Sarcoma-GPA)

scientific article published on 12 February 2020

Diagnosis, prognosis and treatment of patients with gastrointestinal stromal tumour (GIST) and germline mutation of KIT exon 13.

artículo científico publicado en 2013

Discontinuation of imatinib in patients with advanced gastrointestinal stromal tumours after 3 years of treatment: an open-label multicentre randomised phase 3 trial.

artículo científico publicado en 2010

Docetaxel and gemcitabine combination in 133 advanced soft-tissue sarcomas: a retrospective analysis

artículo científico publicado en 2006

Docetaxel and non-small cell lung cancer

artículo científico publicado en 2004

Docetaxel-cisplatin combination (DC) chemotherapy in patients with anthracycline-resistant advanced breast cancer

artículo científico publicado en 1999

Dovitinib in patients with gastrointestinal stromal tumour refractory and/or intolerant to imatinib

artículo científico publicado en 2017

Doxorubicin and ifosfamide for high-grade sarcoma during pregnancy

artículo científico publicado en 2011

Doxorubicin plus dacarbazine, doxorubicin plus ifosfamide, or doxorubicin alone as a first-line treatment for advanced leiomyosarcoma: A propensity score matching analysis from the European Organization for Research and Treatment of Cancer Soft Tiss

artículo científico publicado en 2020

EPIGIST: An observational real-life study on patients with metastatic gastrointestinal stromal tumors receiving imatinib

artículo científico publicado en 2018

ERCC5/XPG, ERCC1, and BRCA1 gene status and clinical benefit of trabectedin in patients with soft tissue sarcoma

artículo científico publicado en 2011

ETIOSARC study : environmental aetiology of sarcomas from a French prospective multicentric population-based case-control study-study protocol

artículo científico publicado en 2019

Effect of Doxorubicin Plus Olaratumab vs Doxorubicin Plus Placebo on Survival in Patients With Advanced Soft Tissue Sarcomas: The ANNOUNCE Randomized Clinical Trial

scientific article published on 01 April 2020

Effect of adjuvant chemotherapy on survival in FNCLCC grade 3 soft tissue sarcomas: a multivariate analysis of the French Sarcoma Group Database

artículo científico publicado en 2010

Effect of the MDM2 antagonist RG7112 on the P53 pathway in patients with MDM2-amplified, well-differentiated or dedifferentiated liposarcoma: an exploratory proof-of-mechanism study

artículo científico publicado en 2012

Efficacy and safety of oral metronomic etoposide in adult patients with metastatic osteosarcoma

scientific article published on 25 November 2020

Efficacy and safety of regorafenib compared to placebo and to post-cross-over regorafenib in advanced non-adipocytic soft tissue sarcoma

Efficacy and safety of regorafenib for advanced gastrointestinal stromal tumours after failure of imatinib and sunitinib (GRID): an international, multicentre, randomised, placebo-controlled, phase 3 trial

artículo científico publicado en 2012

Efficacy and safety of trabectedin as an early treatment for advanced or metastatic liposarcoma and leiomyosarcoma

artículo científico publicado en 2013

Efficacy and safety of trabectedin in patients with advanced or metastatic liposarcoma or leiomyosarcoma after failure of prior anthracyclines and ifosfamide: results of a randomized phase II study of two different schedules

artículo científico publicado en 2009

Efficacy of trabectedin (ecteinascidin-743) in advanced pretreated myxoid liposarcomas: a retrospective study

artículo científico publicado en 2007

Epithelioid sarcoma: need for a multimodal approach to maximize the chances of curative conservative treatment

artículo científico publicado en 2013

Eribulin versus dacarbazine in previously treated patients with advanced liposarcoma or leiomyosarcoma: a randomised, open-label, multicentre, phase 3 trial.

artículo científico publicado en 2016

Erratum

Exceptional Long-lasting Clinical Benefit of Trabectedin in a Patient With Metastatic Undifferentiated Pleomorphic Sarcoma: Postscriptum From the T-Dis Trial

artículo científico publicado en 2019

Expression and role of TYRO3 and AXL as potential therapeutical targets in leiomyosarcoma

artículo científico publicado en 2017

Extraskeletal Myxoid Chondrosarcoma: Clinical and Molecular Characteristics and Outcomes of Patients Treated at Two Institutions

artículo científico publicado en 2020

Feasibility of metronomic oral cyclophosphamide plus prednisolone in elderly patients with inoperable or metastatic soft tissue sarcoma.

artículo científico publicado en 2011

First-line chemotherapy for malignant peripheral nerve sheath tumor (MPNST) versus other histological soft tissue sarcoma subtypes and as a prognostic factor for MPNST: an EORTC soft tissue and bone sarcoma group study

artículo científico publicado en 2010

First-line treatment of metastatic or locally advanced unresectable soft tissue sarcomas with conatumumab in combination with doxorubicin or doxorubicin alone: a phase I/II open-label and double-blind study

artículo científico publicado en 2012

Follow-up of hepatic and peritoneal metastases of gastrointestinal tumors (GIST) under Imatinib therapy requires different criteria of radiological evaluation (size is not everything!!!).

artículo científico publicado en 2008

Frequent EGFR Positivity and Overexpression in High-Grade Areas of Human MPNSTs

artículo científico publicado en 2008

GDC-0449 in patients with advanced chondrosarcomas: a French Sarcoma Group/US and French National Cancer Institute Single-Arm Phase II Collaborative Study

artículo científico publicado en 2013

Gastro-intestinal stromal tumors: news and comments

artículo científico publicado en 2003

Gastrointestinal stromal tumors (GIST): a rare entity, a tumor model for personalized therapy, and yet ten different molecular subtypes

artículo científico

Gastrointestinal stromal tumors II: medical oncology and tumor response assessment

artículo científico publicado en 2009

Gastrointestinal stromal tumors treated with imatinib: monitoring response with contrast-enhanced sonography

artículo científico publicado en 2006

Gastrointestinal stromal tumors: ESMO clinical recommendations for diagnosis, treatment and follow-up

artículo científico publicado en 2007

Gastrointestinal stromal tumours (GISTs): French Intergroup Clinical Practice Guidelines for diagnosis, treatments and follow-up (SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO)

scientific article published on 03 August 2019

Gene Expression Profiling of Desmoid Tumors by cDNA Microarrays and Correlation with Progression-Free Survival.

artículo científico publicado en 2015

Genetic profiling identifies two classes of soft-tissue leiomyosarcomas with distinct clinical characteristics

artículo científico publicado en 2013

Genomic and transcriptomic comparison of post-radiation versus sporadic sarcomas

scientific article published on 26 June 2019

Germline CDKN2A/P16INK4A mutations contribute to genetic determinism of sarcoma ⬇️

artículo científico publicado en 2017

Hemangiopericytoma and antiangiogenic therapy: clinical benefit of antiangiogenic therapy (sorafenib and sunitinib) in relapsed malignant haemangioperyctoma /solitary fibrous tumour

artículo científico publicado en 2009

High expression of both mutant and wild-type alleles of c-kit in gastrointestinal stromal tumors

artículo científico publicado en 2004

High frequency of beta-catenin heterozygous mutations in extra-abdominal fibromatosis: a potential molecular tool for disease management

artículo científico publicado en 2010

High-dose ifosfamide: circumvention of resistance to standard-dose ifosfamide in advanced soft tissue sarcomas

artículo científico publicado en 1995

Hyperthermic isolated limb perfusion in locally advanced soft tissue sarcoma and progressive desmoid-type fibromatosis with TNF 1 mg and melphalan (T1-M HILP) is safe and efficient

artículo científico publicado en 2009

Hyperthermic pelvic perfusion with tumor necrosis factor-α for locally advanced cancers: encouraging results of a phase II study

artículo científico publicado en 2012

Identification of biological factors predictive of response to imatinib mesylate in aggressive fibromatosis

artículo científico publicado en 2010

Imatinib does not induce cardiac left ventricular failure in gastrointestinal stromal tumours patients: Analyis of EORTC-ISG-AGITG study 62005

Imatinib for progressive and recurrent aggressive fibromatosis (desmoid tumors): an FNCLCC/French Sarcoma Group phase II trial with a long-term follow-up

artículo científico publicado en 2010

Imatinib in combination with phosphoinositol kinase inhibitor buparlisib in patients with gastrointestinal stromal tumour who failed prior therapy with imatinib and sunitinib: a Phase 1b, multicentre study

artículo científico publicado en 2020

Imatinib in the treatment of solid tumours

artículo científico publicado en 2009

Imatinib rechallenge in patients with advanced gastrointestinal stromal tumors

artículo científico publicado en 2012

Immune infiltrates are prognostic factors in localized gastrointestinal stromal tumors

artículo científico publicado en 2013

Impact of Concomitant Administration of Gastric Acid-Suppressive Agents and Pazopanib on Outcomes in Soft-Tissue Sarcoma Patients Treated within the EORTC 62043/62072 Trials

scientific article published on 14 February 2019

Impact of Trabectedin Interruption and Subsequent Rechallenge on Progression in Patients With Advanced Soft Tissue Sarcoma: Long-term Follow-up of the T-DIS trial

artículo científico publicado en 2018

Improving treatment results with reference centres for rare cancers: where do we stand?

artículo científico publicado en 2017

Individualized Pazopanib Dosing-Letter

artículo científico publicado en 2016

Initial and late resistance to imatinib in advanced gastrointestinal stromal tumors are predicted by different prognostic factors: a European Organisation for Research and Treatment of Cancer-Italian Sarcoma Group-Australasian Gastrointestinal Trial

artículo científico publicado en 2005

Intensive Induction Chemotherapy without Methotrexate in Adult Patients with Localized Osteosarcoma: Results of the Institut Gustave-Roussy Phase II Trial ⬇️

artículo científico publicado el 1 de noviembre de 2010

Interruption versus continuation of trabectedin in patients with soft-tissue sarcoma (T-DIS): a randomised phase 2 trial

artículo científico publicado en 2015

Is dose de-escalation possible in sarcoma patients treated with enlarged limb sparing resection?

artículo científico publicado en 2017

Is there a role for discontinuing imatinib in patients with advanced gastrointestinal stromal tumour?

scientific article published on July 2009

KIT mutations and dose selection for imatinib in patients with advanced gastrointestinal stromal tumours

artículo científico publicado en 2006

Key messages from the BFR14 trial of the French Sarcoma Group

artículo científico publicado en 2016

Long-term outcome and effect of maintenance therapy in patients with advanced sarcoma treated with trabectedin: an analysis of 181 patients of the French ATU compassionate use program

artículo científico publicado en 2013

Long-term outcome of dasatinib first-line treatment in gastrointestinal stromal tumor: A multicenter, 2-stage phase 2 trial (Swiss Group for Clinical Cancer Research 56/07).

artículo científico publicado en 2018

Long-term outcome of molecular subgroups of GIST patients treated with standard-dose imatinib in the BFR14 trial of the French Sarcoma Group

artículo científico publicado en 2015

Long-term outcomes of oral vinorelbine in advanced, progressive desmoid fibromatosis and influence of CTNNB1 mutational status

artículo científico publicado en 2020

Long-term recurrence of soft tissue sarcomas: Prognostic factors and implications for prolonged follow-up

Low level of baseline circulating VEGF-A is associated with better outcome in patients with vascular sarcomas receiving sorafenib: an ancillary study from a phase II trial

artículo científico publicado en 2013

Lymphopenia as a prognostic factor for overall survival in advanced carcinomas, sarcomas, and lymphomas

artículo científico publicado en 2009

Management of Gastrointestinal Stromal Tumour: Current Practices and Visions for the Future

artículo científico

Management of desmoid tumours: A nationwide survey of labelled reference centre networks in France

artículo científico publicado en 2016

Management of gastrointestinal stromal tumours of limited size: proposals from a French panel of physicians

artículo científico publicado en 2011

Management of locoregional recurrence after radical resection of a primary nonmetastatic retroperitoneal soft tissue sarcoma: The Gustave Roussy experience

scientific article published on 06 November 2018

Mapping the literature: role of trabectedin as a new chemotherapy option in advanced pretreated soft tissue sarcoma

artículo científico publicado en 2009

Masitinib in advanced gastrointestinal stromal tumor (GIST) after failure of imatinib: a randomized controlled open-label trial

artículo científico publicado en 2014

Medium levels of transcription and replication related chromosomal instability are associated with poor clinical outcome

artículo científico publicado en 2021

Metastases from cancers of unknown primary site. Data from 302 autopsies

artículo científico publicado el 21 de septiembre de 1991

Multidrug resistance proteins in gastrointestinal stromal tumors: site-dependent expression and initial response to imatinib

artículo científico publicado en 2005

NBTXR3, a first-in-class radioenhancer hafnium oxide nanoparticle, plus radiotherapy versus radiotherapy alone in patients with locally advanced soft-tissue sarcoma (Act.In.Sarc): a multicentre, phase 2-3, randomised, controlled trial

scientific article published on 08 July 2019

NCCN Task Force report: management of patients with gastrointestinal stromal tumor (GIST)--update of the NCCN clinical practice guidelines.

artículo científico publicado en 2007

NKp30 isoforms and NKp30 ligands are predictive biomarkers of response to imatinib mesylate in metastatic GIST patients

artículo científico publicado en 2016

Natural killer cell IFN-gamma levels predict long-term survival with imatinib mesylate therapy in gastrointestinal stromal tumor-bearing patients

artículo científico publicado en 2009

Neoadjuvant Chemotherapy, Concurrent Chemoradiation, and Adjuvant Chemotherapy for High-Risk Extremity Soft Tissue Sarcoma

artículo científico publicado en 2018

Neoadjuvant imatinib in locally advanced gastrointestinal stromal tumors (GIST): the EORTC STBSG experience

artículo científico publicado en 2013

Neoadjuvant imatinib in patients with locally advanced non metastatic GIST in the prospective BFR14 trial

artículo científico publicado en 2011

Nilotinib in locally advanced pigmented villonodular synovitis: a multicentre, open-label, single-arm, phase 2 trial.

artículo científico publicado en 2018

Nilotinib versus imatinib as first-line therapy for patients with unresectable or metastatic gastrointestinal stromal tumours (ENESTg1): a randomised phase 3 trial

artículo científico publicado en 2015

Notch pathway inhibition with LY3039478 in soft tissue sarcoma and gastrointestinal stromal tumours

scientific article published on 12 September 2018

Novel mode of action of c-kit tyrosine kinase inhibitors leading to NK cell-dependent antitumor effects

artículo científico publicado en 2004

Optimizing the use of trabectedin for advanced soft tissue sarcoma in daily clinical practice

artículo científico

Optimizing tyrosine kinase inhibitor therapy in gastrointestinal stromal tumors: exploring the benefits of continuous kinase suppression

artículo científico publicado en 2013

Outcome of 449 adult patients with rhabdomyosarcoma: an observational ambispective nationwide study

artículo científico publicado en 2018

Outcome of Patients with Soft-Tissue Sarcomas: An Age-Specific Conditional Survival Analysis

scientific article published on 23 April 2019

Outcome of chemotherapy in advanced synovial sarcoma patients: Review of 15 clinical trials from the European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group; setting a new landmark for studies in this entity

artículo científico publicado en 2016

Outcome of patients with advanced gastro-intestinal stromal tumours crossing over to a daily imatinib dose of 800 mg after progression on 400 mg.

artículo científico publicado en 2005

Outcomes of Elderly Patients with Advanced Soft Tissue Sarcoma Treated with First-Line Chemotherapy: A Pooled Analysis of 12 EORTC Soft Tissue and Bone Sarcoma Group Trials.

artículo científico publicado en 2018

Outcomes of patients with metastatic gastrointestinal stromal tumors (GIST) treated with multi-kinase inhibitors other than imatinib as first-line treatment

artículo científico publicado en 2020

PARP1 expression in soft tissue sarcomas is a poor-prognosis factor and a new potential therapeutic target

artículo científico publicado en 2019

PDL1 expression is a poor-prognosis factor in soft-tissue sarcomas.

artículo científico publicado en 2017

Paclitaxel Given Once Per Week With or Without Bevacizumab in Patients With Advanced Angiosarcoma: A Randomized Phase II Trial

artículo científico publicado en 2015

Patterns of care and outcome Radiation-Induced Soft Tissue Sarcomas

artículo científico publicado en 2018

Patterns of care and outcomes of patients with METAstatic soft tissue SARComa in a real-life setting: the METASARC observational study

artículo científico publicado en 2017

Patterns of care, prognosis, and survival in patients with metastatic gastrointestinal stromal tumors (GIST) refractory to first-line imatinib and second-line sunitinib

artículo científico publicado en 2011

Pazopanib for metastatic soft-tissue sarcoma (PALETTE): a randomised, double-blind, placebo-controlled phase 3 trial

artículo científico publicado en 2012

Pazopanib for treatment of typical solitary fibrous tumours: a multicentre, single-arm, phase 2 trial

artículo científico publicado en 2020

Pazopanib or methotrexate-vinblastine combination chemotherapy in adult patients with progressive desmoid tumours (DESMOPAZ): a non-comparative, randomised, open-label, multicentre, phase 2 study

artículo científico publicado en 2019

Pazopanib plus best supportive care versus best supportive care alone in advanced gastrointestinal stromal tumours resistant to imatinib and sunitinib (PAZOGIST): a randomised, multicentre, open-label phase 2 trial

artículo científico publicado en 2016

Pazopanib, a multikinase angiogenesis inhibitor, in patients with relapsed or refractory advanced soft tissue sarcoma: a phase II study from the European organisation for research and treatment of cancer-soft tissue and bone sarcoma group (EORTC stu

artículo científico publicado en 2009

Perioperative Management of Extremity Soft Tissue Sarcomas.

artículo científico publicado en 2017

Personalizing the Approach to Retroperitoneal Soft Tissue Sarcoma: Histology-specific Patterns of Failure and Postrelapse Outcome after Primary Extended Resection

artículo científico publicado en 2014

Pharmacogenetic Study of Trabectedin-Induced Severe Hepatotoxicity in Patients with Advanced Soft Tissue Sarcoma

artículo científico publicado en 2020

Pharmacokinetic-Pharmacodynamic Relationships of Imatinib and Its Main Metabolite in Patients with Advanced Gastrointestinal Stromal Tumors

scientific article published on 01 October 2006

Phase I clinical trial combining imatinib mesylate and IL-2 in refractory cancer patients: IL-2 interferes with the pharmacokinetics of imatinib mesylate

artículo científico publicado en 2013

Phase I clinical trial combining imatinib mesylate and IL-2: HLA-DR(+) NK cell levels correlate with disease outcome

artículo científico publicado en 2013

Phase I combination study of trabectedin and doxorubicin in patients with soft-tissue sarcoma

artículo científico publicado en 2008

Phase II study of ET-743 in advanced soft tissue sarcomas: a European Organisation for the Research and Treatment of Cancer (EORTC) soft tissue and bone sarcoma group trial

artículo científico publicado en 2005

Phase II study of oral masitinib mesilate in imatinib-naïve patients with locally advanced or metastatic gastro-intestinal stromal tumour (GIST).

artículo científico publicado en 2010

Phase III Trial of Two Investigational Schedules of Ifosfamide Compared With Standard-Dose Doxorubicin in Advanced or Metastatic Soft Tissue Sarcoma: A European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group Stud

article

Place and technical aspects of external beam radiation therapy in the treatment of adult soft tissue sarcomas

artículo científico publicado en 2005

Postoperative Outcome of Surgery with Pancreatic Resection for Retroperitoneal Soft Tissue Sarcoma: Results of a Retrospective Bicentric Analysis on 50 Consecutive Patients

artículo científico publicado en 2020

Predicting toxicities for patients with advanced gastrointestinal stromal tumours treated with imatinib: A study of the European Organisation for Research and Treatment of Cancer, the Italian Sarcoma Group, and the Australasian Gastro-Intestinal Tria

article

Pregnancy in Women with Metastatic Sarcomas

scientific article published on 19 September 2020

Preserving quality of life as a key treatment goal in advanced soft tissue sarcomas

artículo científico publicado en 2018

Primary Extremity Soft Tissue Sarcomas: Does Local Control Impact Survival?

scientific article published on 04 August 2016

Primary cardiac sarcomas: a retrospective study of the French Sarcoma Group.

artículo científico publicado en 2013

Primary pleuropulmonary sarcoma: a rare disease entity

artículo científico publicado en 2012

Primary retroperitoneal sarcomas: a multivariate analysis of surgical factors associated with local control

artículo científico publicado en 2008

Prognosis and predictive value of KIT exon 11 deletion in GISTs

artículo científico publicado en 2009

Prognostic and predictive factors for angiosarcoma patients receiving paclitaxel once weekly plus or minus bevacizumab: an ancillary study derived from a randomized clinical trial

scientific article published on 11 October 2018

Prognostic and predictive factors for outcome to first-line ifosfamide-containing chemotherapy for adult patients with advanced soft tissue sarcomas

article by Stefan Sleijfer et al published January 2010 in European Journal of Cancer

Prognostic factors and impact of adjuvant treatments on local and metastatic relapse of soft-tissue sarcoma patients in the competing risks setting

artículo científico publicado en 2014

Prognostic factors for soft tissue sarcoma patients with lung metastases only who are receiving first-line chemotherapy: An exploratory, retrospective analysis of the European Organization for Research and Treatment of Cancer-Soft Tissue and Bone Sa

artículo científico publicado en 2018

Prognostic factors influencing progression-free survival determined from a series of sporadic desmoid tumors: a wait-and-see policy according to tumor presentation

artículo científico publicado en 2011

Progressive Desmoid Tumor: Radiomics Compared With Conventional Response Criteria for Predicting Progression During Systemic Therapy-A Multicenter Study by the French Sarcoma Group

scientific article published on 29 September 2020

Prospective multicentric randomized phase III study of imatinib in patients with advanced gastrointestinal stromal tumors comparing interruption versus continuation of treatment beyond 1 year: the French Sarcoma Group.

artículo científico publicado en 2007

Quality of Surgery and Outcome in Localized Gastrointestinal Stromal Tumors Treated Within an International Intergroup Randomized Clinical Trial of Adjuvant Imatinib

scientific article published on 01 April 2020

Quality of life and patients' expectations in soft tissue sarcoma

scientific article published on 01 May 2018

Quantitative functional imaging by Dynamic Contrast Enhanced Ultrasonography (DCE-US) in GIST patients treated with masatinib

artículo científico publicado en 2010

REGOSARC: Regorafenib versus placebo in doxorubicin-refractory soft-tissue sarcoma-A quality-adjusted time without symptoms of progression or toxicity analysis

artículo científico publicado en 2017

Real-world evidence of the efficacy and tolerability of trabectedin in patients with advanced soft-tissue sarcoma

artículo científico publicado en 2020

Recent advances in managing gastrointestinal stromal tumor

artículo científico publicado en 2017

Recombinant erythropoietin for the anaemia of patients with advanced Gastrointestinal Stromal Tumours (GIST) receiving imatinib: an active agent only in non progressive patients

artículo científico publicado en 2012

Recommendations for the management of GIST patients

artículo científico publicado en 2005

Relationship between imatinib trough concentration and outcomes in the treatment of advanced gastrointestinal stromal tumours in a real-life setting

artículo científico publicado en 2016

Reply to Letter: A Role for Adjuvant RFA in Managing Hepatic Metastases From Gastrointestinal Stromal Tumors (GIST) After Treatment With Targeted Systemic Therapy Using Kinase Inhibitors

artículo científico publicado en 2013

Reply to Y. Nishida et al

Resection of Uninvolved Adjacent Organs Can Be Part of Surgery for Retroperitoneal Soft Tissue Sarcoma

Resection of uninvolved adjacent organs can be part of surgery for retroperitoneal soft tissue sarcoma

artículo científico publicado en 2009

Results of API-AI based regimen in osteosarcoma adult patients included in the French OS2006/Sarcome-09 study

scientific article published on 19 July 2019

Results of an international randomized phase III trial of the mammalian target of rapamycin inhibitor ridaforolimus versus placebo to control metastatic sarcomas in patients after benefit from prior chemotherapy

artículo científico publicado en 2013

Retroperitoneal sarcomas: patterns of care at diagnosis, prognostic factors and focus on main histological subtypes: a multicenter analysis of the French Sarcoma Group

artículo científico publicado en 2014

Retroperitoneal sarcomas: patterns of care in advanced stages, prognostic factors and focus on main histological subtypes: a multicenter analysis of the French Sarcoma Group

artículo científico publicado en 2014

Role of Chemotherapy, VEGFR Inhibitors, and mTOR Inhibitors in Advanced Perivascular Epithelioid Cell Tumors (PEComas)

artículo científico publicado en 2019

Role of computed tomography in the follow-up of hepatic and peritoneal metastases of GIST under imatinib mesylate treatment: a prospective study of 54 patients

artículo científico publicado en 2005

Safety and efficacy of Pazopanib in advanced soft tissue sarcoma: PALETTE (EORTC 62072) subgroup analyses

artículo científico publicado en 2019

Safety and efficacy of regorafenib in patients with advanced soft tissue sarcoma (REGOSARC): a randomised, double-blind, placebo-controlled, phase 2 trial

artículo científico publicado en 2016

Safety of Imatinib Mesylate in a Multicenter Expanded Access Program in Adult Patients with Gastrointestinal Stromal Tumors in the Adjuvant Setting

scientific article published on 24 September 2019

Safety of raltegravir-based antiretroviral therapy in HIV-infected patients receiving multi-kinase inhibitors

artículo científico publicado en 2016

Sarcomas in patients over 90: Natural history and treatment-A nationwide study over 6 years

scientific article published on 15 April 2019

Sorafenib for patients with advanced angiosarcoma: a phase II Trial from the French Sarcoma Group (GSF/GETO).

artículo científico publicado en 2012

Sorafenib in patients with locally advanced and metastatic chordomas: a phase II trial of the French Sarcoma Group (GSF/GETO)

artículo científico publicado en 2015

Sorafenib in patients with progressive epithelioid hemangioendothelioma: a phase 2 study by the French Sarcoma Group (GSF/GETO).

artículo científico publicado en 2013

Spontaneous regression of primary abdominal wall desmoid tumors: more common than previously thought.

artículo científico publicado en 2013

Stratégie de prise en charge des tumeurs primitives

Study protocol of REGOSARC trial: activity and safety of regorafenib in advanced soft tissue sarcoma: a multinational, randomized, placebo-controlled, phase II trial

artículo científico publicado en 2015

Surgical versus non-surgical approach in primary desmoid-type fibromatosis patients: A nationwide prospective cohort from the French Sarcoma Group

artículo científico publicado en 2017

Surrogate endpoints in advanced sarcoma trials: a meta-analysis

artículo científico publicado en 2018

Systemic treatments in MDM2 positive intimal sarcoma: A multicentre experience with anthracycline, gemcitabine, and pazopanib within the World Sarcoma Network

scientific article published on 19 September 2019

TP53 mutations emerge with HDM2 inhibitor SAR405838 treatment in de-differentiated liposarcoma

artículo científico publicado en 2016

Targeted cancer therapies.

artículo científico publicado en 2005

Targeting CDK4 (cyclin-dependent kinase) amplification in liposarcoma: A comprehensive review

artículo científico publicado en 2020

Ten-Year Progression-Free and Overall Survival in Patients With Unresectable or Metastatic GI Stromal Tumors: Long-Term Analysis of the European Organisation for Research and Treatment of Cancer, Italian Sarcoma Group, and Australasian Gastrointesti

artículo científico publicado en 2017

The cost-saving effect of centralized histological reviews with soft tissue and visceral sarcomas, GIST, and desmoid tumors: The experiences of the pathologists of the French Sarcoma Group.

artículo científico publicado en 2018

The current reality of soft tissue sarcomas: advances, controversies, areas for improvement, and promising new treatments

scientific article published on 29 April 2020

The importance of treating by histological subtype in advanced soft tissue sarcoma

artículo científico publicado en 2017

The off-label use of targeted therapies in sarcomas: the OUTC'S program

artículo científico publicado en 2014

The sum of gains and losses of genes encoding the protein tyrosine kinase targets predicts response to multi-kinase inhibitor treatment: Characterization, validation, and prognostic value

artículo científico publicado en 2015

Time to Definitive Failure to the First Tyrosine Kinase Inhibitor in Localized GI Stromal Tumors Treated With Imatinib As an Adjuvant: A European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group Intergroup Randomi

artículo científico publicado en 2015

Trabectedin in advanced desmoplastic round cell tumors: a retrospective single-center series

artículo científico publicado en 2016

Trabectedin in advanced synovial sarcomas: a multicenter retrospective study from four European institutions and the Italian Rare Cancer Network

artículo científico publicado en 2015

Trabectedin in combination with doxorubicin for first-line treatment of advanced uterine or soft-tissue leiomyosarcoma (LMS-02): a non-randomised, multicentre, phase 2 trial

artículo científico publicado en 2015

Trabectedin in patients with advanced soft tissue sarcoma: a retrospective national analysis of the French Sarcoma Group

artículo científico publicado en 2015

Treating soft tissue sarcomas with adjuvant chemotherapy.

artículo científico publicado en 2011

Treatment of advanced gastrointestinal stromal tumors in patients over 75 years old: clinical and pharmacological implications.

artículo científico publicado en 2012

Trends in survival for patients with metastatic soft-tissue sarcoma

artículo científico publicado en 2010

Tumor genotype is an independent prognostic factor in primary gastrointestinal stromal tumors of gastric origin: a european multicenter analysis based on ConticaGIST.

artículo científico publicado en 2014

Unusual problems in breast cancer and a rare lung cancer case. Case 2. Aggressive fibromatosis of the chest wall arising near a breast prosthesis

scientific article published on 01 June 2003

Use of PD-1 Targeting, Macrophage Infiltration, and IDO Pathway Activation in Sarcomas: A Phase 2 Clinical Trial

artículo científico publicado en 2018

Validated prediction of clinical outcome in sarcomas and multiple types of cancer on the basis of a gene expression signature related to genome complexity

artículo científico publicado en 2010

When Imaging Becomes Clinically Relevant: Multikinase Inhibitor-related Pancreatic Insufficiency and Pancreatic Atrophy

artículo científico publicado en 2017

[French Sarcoma Group proposals for management of sarcoma patients during COVID-19 outbreak]

scientific article published on 01 April 2020

[Management of recurrent soft tissue sarcoma of the retroperitoneum]

artículo científico publicado en 2004

[Neoadjuvant chemotherapy in sarcoma]

artículo científico publicado en 2006

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda